| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $12.4M | -18.2% | -32.7% |
| Cost of Revenue | $4.8M | -13.2% | -14.8% |
| Gross Profit | $7.6M | -21.0% | -40.7% |
| R&D Expense | $0 | — | -100.0% |
| SG&A Expense | $5.0M | -1.9% | +21.0% |
| Operating Income | -$4.1M | -106.3% | -267.9% |
| Pre-tax Income | -$5.6M | +47.0% | -246.9% |
| Income Tax | $10K | — | +108.2% |
| Net Income | -$5.6M | +46.9% | -240.7% |
| EPS (Basic) | -$0.53 | +49.5% | -181.5% |
| EPS (Diluted) | -$0.53 | +49.5% | -352.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $26.7M | -11.0% | +47.0% |
| Accounts Receivable | $24.5M | -20.8% | -31.6% |
| Inventory | $7.5M | -13.8% | -32.5% |
| Current Assets | $67.3M | -11.7% | -7.2% |
| Total Assets | $111.7M | -8.5% | -10.1% |
| Current Liabilities | $60.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.1M | — | — |
| Capital Expenditures | $17K | — | — |
| Investing Cash Flow | -$17K | — | — |
| Financing Cash Flow | -$3.1M | — | — |
| Free Cash Flow | -$1.1M | — | — |
| -15.2% |
| Long-term Debt | $9.5M | -4.5% | +0.1% |
| Stockholders' Equity | $35.1M | +147.5% | +0.7% |